Home
About us
Company Overview
Corporate Culture
Core Team
Milestones
Partners
R&D
Production Base
Internationalization
Our Products
Products
R&D Pipeline
News
Company News
Industry News
Enterprise Features
Contact us
Contact us
Join us
Language
English
中文
Home
About us
R&D
Production Base
Internationalization
Our Products
Our Products
Products
R&D Pipeline
News
News
Company News
Industry News
Enterprise Features
Contact us
Contact us
Contact us
Join us
Home
Internationalization
Adherence to International Strategy
Import and License-in
2019
2019
2024-01-03
5 In-licensed FDA approved products, including Oseltamivir Oral Suspension
